Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 299

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 299
---

    Deficit 

    Balance
    at January 1, 2023 (Predecessor) 
     5,155,703  
     4,077,560  
     22,764,764  
     38,023,784  
     5,830  
     1  
     929,463  
     (35,800,244) 
     (34,870,780)
  
    Issuance
    of common stock from exercise of stock options 
     -  
     -  
     -  
     -  
     15  
           -  
     5,766  
     -  
     5,766 
  
    Stock
    based compensation expense 
     -  
     -  
     -  
     -  
     -  
     -  
     96,896  
     -  
     96,896 
  
    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (7,289,577) 
     (7,289,577)
  
    Balance
    at December 31, 2023 (Predecessor) 
     5,155,703  
     4,077,560  
     22,764,764  
     38,023,784  
     5,845  
     1  
     1,032,125  
     (43,089,821) 
     (42,057,695)
  
    Stock
    based compensation expense 
     -  
     -  
     -  
     -  
     -  
     -  
     4,431  
     -  
     4,431 
  
    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (572,211) 
     (572,211)
  
    Balance
    at February 13, 2024 (Predecessor)